Fig 1.
Schematic illustration of the study design.
Table 1.
Demographics and clinical characteristics of patients with SFTS.
Table 2.
Symptomatic and signs characteristics of patients with SFTSV infection on admission.
Table 3.
Laboratory results of patients with SFTS on admission.
Fig 2.
Receiver operating characteristic (ROC) curves for evaluating the predictive ability of the factors associated with severity of SFTS on admission.
(A) The combination of the EOS% and BAS% (orange line) had an AUC of 0.82 (P = 0.000); AST (blue line) had an AUC of 0.805 (P = 0.000); DBIL (red line) had an AUC of 0.777 (P = 0.000); Age (green line) had an AUC of 0.764 (P = 0.000). (B) The combination of the EOS% and BAS% (green line) had an AUC of 0.828 (P = 0.000); De-Ritis ratio (red line) had an AUC of 0.775 and the cut-off value was 2.69 (P = 0.000); NLR (blue line) had an AUC of 0.611 and the cut-off value was 2.27 (P = 0.083). Abbreviations: EOS: Eosinophils, BAS: Basophils, AST: Aspartate aminotransferase, DBIL: Direct Bilirubin, AUC: Area under the ROC curve, CI: Confidence interval, De-Ritis ratio: AST/ALT ratio, NLR: Neutrophil-to-lymphocyte ratio.
Table 4.
Predictive value of risk factors for SFTS severity.
Table 5.
Clinical characteristics of patients with SFTS, according the EOS% cutoff value on admission.
Table 6.
Clinical characteristics of patients with SFTS, according to the BAS% cutoff value on admission.
Fig 3.
Correlation among circulating EOS%, BAS%, and laboratory parameters in SFTS patients.
Abbreviations: MON: Monocyte, EOS: Eosinophils, BAS: Basophils, PCT: Procalcitonin, CRP: C-reactive protein, LDH: Lactate dehydrogenase, CK: Creatine phosphokinase, AST: Aspartate aminotransferase, ALB: Albumin, GGT: γ-glutamyl transferase, ALP: Alkaline phosphatase, CREA: Creatinine.